Top 10 Companies in the Pharmaceutical Excipients for Peptide Drug Synthesis Market (2026): Market Leaders Powering Global Innovation

MARKET INSIGHTS

Global pharmaceutical excipients for peptide drug synthesis market size was valued at USD 1712 million in 2024 and is projected to reach USD 2678 million by 2032, exhibiting a CAGR of 7.3% during the forecast period.

Pharmaceutical excipients for peptide drug synthesis are inactive ingredients used to enhance solubility, stability, and bioavailability during peptide drug development. These specialized formulations include buffers, surfactants, antioxidants, and lyoprotectants that optimize manufacturing conditions while ensuring product purity and shelf‑life extension. The increasing complexity of peptide therapeutics (such as GLP‑1 analogs for diabetes) is driving demand for high‑performance excipients that can address stability challenges inherent in large‑molecule formulations.

Market growth is propelled by the booming peptide therapeutics sector, which reached USD 39.5 billion in 2023. North America dominates with 42% market share, while Asia‑Pacific shows the fastest growth at 9.1% CAGR through 2032. Recent innovations include novel cyclodextrin‑based solubilizers by Merck and pH‑stabilizing buffer systems from Lubrizol Life Science. With over 140 peptide drugs in clinical trials as of 2024, excipient manufacturers are investing heavily in GMP‑compliant production facilities to meet stringent regulatory requirements.

Pharmaceutical Excipients for Peptide Drug Synthesis Market – View in Detailed Research Report

10️⃣ 1. Merck KGaA

Headquarters: Darmstadt, Germany
Key Offering: High‑purity buffers, cyclodextrin solubilizers, lyoprotectants

Merck KGaA continues to dominate the excipient landscape with a portfolio that supports complex peptide formulations. Their GMP‑certified facilities produce USP/EP‑grade buffers and innovative cyclodextrin derivatives that enhance peptide solubility and stability.

Sustainability & Growth Initiatives:

• Investing in green chemistry for buffer synthesis
• Expanding R&D for next‑generation lyoprotectants
• Partnerships with biotech firms to co‑develop delivery systems

9️⃣ 2. Hunan Er‑kang Pharmaceutical

Headquarters: Changsha, China
Key Offering: USP/EP‑grade buffers, chelating agents, surfactants

Hunan Er‑kang has rapidly scaled its production to meet domestic and international demand for peptide excipients, offering cost‑effective solutions without compromising quality.

Sustainability & Growth Initiatives:

• Upgrading facilities to ISO 9001 and GMP standards
• Developing biodegradable surfactants
• Expanding export footprint to Southeast Asia

8️⃣ 3. Anhui Sunhere Pharmaceutical Excipients

Headquarters: Hefei, China
Key Offering: Antioxidants, stabilizing agents, buffer blends

Sunhere focuses on advanced antioxidant formulations that protect peptides from oxidative degradation during manufacturing and storage.

Sustainability & Growth Initiatives:

• Investing in renewable raw material sourcing
• Collaborating with universities on smart excipient research
• Expanding product lines to include nanocarrier excipients

7️⃣ 4. Lubrizol Life Science

Headquarters: Northbrook, Illinois, USA
Key Offering: pH‑stabilizing buffer systems, surfactants, lyoprotectants

Lubrizol has gained traction through its innovative solubilization technologies, particularly cyclodextrin‑based systems that improve peptide solubility by up to 40%.

Sustainability & Growth Initiatives:

• Developing low‑water buffers for green manufacturing
• Strategic acquisitions of niche excipient producers
• Expanding global distribution network in Asia‑Pacific

6️⃣ 5. Suzhou Highfine Biotech

Headquarters: Suzhou, China
Key Offering: High‑purity buffers, chelating agents, stabilizing excipients

With a new USD 50 million facility (2024), Suzhou Highfine has increased buffer production capacity by 40%, positioning it as a key supplier for peptide manufacturers.

Sustainability & Growth Initiatives:

• Adopting energy‑efficient production processes
• Investing in AI‑driven formulation optimization
• Expanding R&D for multi‑functional excipient blends

5️⃣ 6. Kingchem

Headquarters: Nanjing, China
Key Offering: Surfactants, antioxidants, delivery agents

Kingchem has forged partnerships with CDMOs in Europe, marking its first major foray into international markets and broadening its customer base.

Sustainability & Growth Initiatives:

• Implementing circular economy practices in raw material sourcing
• Developing biodegradable surfactants
• Expanding global supply chain resilience

4️⃣ 7. BroadPharm

Headquarters: Richmond, USA
Key Offering: Customized excipient solutions for complex peptide formulations

BroadPharm specializes in multi‑functional excipient systems that combine stabilizers, permeation enhancers, and bioavailability boosters in single‑component solutions.

Sustainability & Growth Initiatives:

• Investing in green chemistry for excipient synthesis
• Collaborating with biotech firms on oral peptide delivery
• Expanding manufacturing footprint in North America

3️⃣ 8. Livzon Pharmaceutical

Headquarters: Shanghai, China
Key Offering: Antioxidants, stabilizing agents, buffer blends

Livzon focuses on high‑purity excipients that enhance peptide stability and extend shelf life, catering to both domestic and export markets.

Sustainability & Growth Initiatives:

• Upgrading to ISO 14001 environmental standards
• Developing low‑VOC excipient formulations
• Expanding R&D for smart excipient technologies

2️⃣ 9. BASF

Headquarters: Ludwigshafen, Germany
Key Offering: Surfactants, antioxidants, buffer systems

BASF leverages its extensive chemical expertise to produce high‑performance excipients that meet stringent regulatory requirements for peptide drugs.

Sustainability & Growth Initiatives:

• Investing in renewable raw materials
• Developing eco‑friendly surfactants
• Expanding global distribution network

1️⃣ 10. Ciba Vision

Headquarters: Zürich, Switzerland
Key Offering: High‑purity buffers, lyoprotectants, advanced stabilizers

Ciba Vision provides GMP‑certified excipients that support complex peptide formulations, with a focus on personalized medicine and biopharmaceutical innovation.

Sustainability & Growth Initiatives:

• Adopting green chemistry for excipient production
• Collaborating with biotech firms on next‑generation delivery systems
• Expanding R&D for smart excipient solutions

Download FREE Sample Report: Pharmaceutical Excipients for Peptide Drug Synthesis Market – View in Detailed Research Report
Get Full Report: Pharmaceutical Excipients for Peptide Drug Synthesis Market – View in Detailed Research Report

🌍 Outlook: The Future of Pharmaceutical Excipients for Peptide Drug Synthesis Is Cleaner and Smarter

As peptide therapeutics continue to rise, the demand for advanced excipients will accelerate. Regulatory frameworks are evolving to support rapid development, while manufacturers invest in sustainable chemistry and smart excipient technologies to reduce environmental impact and improve patient outcomes.

📈 Key Trends Shaping the Market:

• Growth of high‑potency injectable peptide segments driving premium pricing.
• Strategic biotech partnerships accelerating multi‑functional excipient development.
• Adoption of smart excipients for controlled release and targeted delivery.
• Increased focus on green chemistry and renewable raw materials.
• Expansion of biopharmaceutical R&D investments in the U.S. and China.